Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) closed the day trading at $24.53 down -3.54% from the previous closing price of $25.43. In other words, the price has decreased by -$0.90 from its previous closing price. On the day, 481583 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of BCYC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.08 and its Current Ratio is at 8.08. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On July 28, 2022, Barclays started tracking the stock assigning a Overweight rating and target price of $30.Barclays initiated its Overweight rating on July 28, 2022, with a $30 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 03 ’24 when Lee Kevin sold 8,703 shares for $17.50 per share. The transaction valued at 152,302 led to the insider holds 390,428 shares of the business.
Crockett Nigel sold 2,643 shares of BCYC for $46,252 on Jan 03 ’24. The Chief Business Officer now owns 48,716 shares after completing the transaction at $17.50 per share. On Jan 03 ’24, another insider, Skynner Michael, who serves as the Chief Technology Officer of the company, sold 2,643 shares for $17.50 each. As a result, the insider received 46,252 and left with 95,839 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCYC now has a Market Capitalization of 929.20M and an Enterprise Value of 447.74M. For the stock, the TTM Price-to-Sale (P/S) ratio is 38.45 while its Price-to-Book (P/B) ratio in mrq is 2.81. Its current Enterprise Value per Revenue stands at 16.60 whereas that against EBITDA is -2.64.
Stock Price History:
Over the past 52 weeks, BCYC has reached a high of $28.91, while it has fallen to a 52-week low of $12.54. The 50-Day Moving Average of the stock is 21.65, while the 200-Day Moving Average is calculated to be 20.60.
Shares Statistics:
Over the past 3-months, BCYC traded about 352.99K shares per day on average, while over the past 10 days, BCYC traded about 381.55k shares per day. A total of 42.43M shares are outstanding, with a floating share count of 41.93M. Insiders hold about 1.19% of the company’s shares, while institutions hold 76.14% stake in the company. Shares short for BCYC as of Feb 29, 2024 were 2.76M with a Short Ratio of 7.83, compared to 3.78M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.30% and a Short% of Float of 7.39%.
Earnings Estimates
Current recommendations for the stock of the company come from 11 analysts. On average, analysts expect EPS of -$1.24 for the current quarter, with a high estimate of -$1.03 and a low estimate of -$1.4, while EPS last year was -$1.3. The consensus estimate for the next quarter is -$1.3, with high estimates of -$1.12 and low estimates of -$1.51.
Analysts are recommending an EPS of between -$4.43 and -$5.9 for the fiscal current year, implying an average EPS of -$5.18. EPS for the following year is -$5.52, with 12 analysts recommending between -$4.59 and -$7.05.
Revenue Estimates
A total of 12 analysts have provided revenue estimates for BCYC’s current fiscal year. The highest revenue estimate was $53.4M, while the lowest revenue estimate was $10M, resulting in an average revenue estimate of $27.48M. In the same quarter a year ago, actual revenue was $26.98M, up 1.90% from the average estimate.
